A single high-dose irradiation changes accumulation of methotrexate and gene expression levels of SLC and ABC transporters in cancer cells
暂无分享,去创建一个
Tatsuya Seki | T. Nakanishi | R. Nishii | Shiho Hirota | I. Tamai | Masato Kobayashi | Kodai Nishi | Asuka Mizutani | K. Kawai | Kana Yamazaki | Yuka Muranaka | Kakeru Sato
[1] P. Day,et al. Cell Surface Transporters and Novel Drug Developments , 2022, Frontiers in Pharmacology.
[2] A. Karlsson,et al. Surface guided frameless positioning for lung stereotactic body radiation therapy , 2021, Journal of applied clinical medical physics.
[3] H. Lei,et al. Baicalein modulates the radiosensitivity of cervical cancer cells in vitro via miR-183 and the JAK2/STAT3 signaling pathway. , 2021, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.
[4] A. Ascolese,et al. Stereotactic Body Radiation Therapy Boost in Patients With Cervical Cancer Ineligible for Brachytherapy. , 2021, Cancer diagnosis & prognosis.
[5] U. Abacıoğlu,et al. Stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of liver metastases in oligometastatic patients: initial clinical experience , 2021, Radiation oncology journal.
[6] Wei Wei,et al. The effects of drug transporters on the efficacy of methotrexate in the treatment of rheumatoid arthritis. , 2021, Life sciences.
[7] W. Yu,et al. Polymeric Nanoscale Drug Carriers Mediate the Delivery of Methotrexate for Developing Therapeutic Interventions Against Cancer and Rheumatoid Arthritis , 2020, Frontiers in Oncology.
[8] A. Meeson,et al. Solute transporters and malignancy: establishing the role of uptake transporters in breast cancer and breast cancer metastasis , 2020, Cancer and Metastasis Reviews.
[9] J. Thariat,et al. Stereotactic radiation therapy for breast cancer in the elderly , 2020, Translational cancer research.
[10] T. Yasugi,et al. Determining the recommended dose of stereotactic body radiotherapy boost in patients with cervical cancer who are unsuitable for intracavitary brachytherapy: a phase I dose-escalation study. , 2019, Japanese journal of clinical oncology.
[11] anonymous,et al. Comprehensive review , 2019 .
[12] E. Baldini,et al. Neoadjuvant Chemotherapy, Concurrent Chemoradiation, and Adjuvant Chemotherapy for High-Risk Extremity Soft Tissue Sarcoma. , 2018, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.
[13] Barton E Slatko,et al. Overview of Next‐Generation Sequencing Technologies , 2018, Current protocols in molecular biology.
[14] A. Swaminath,et al. Stereotactic body radiation therapy (SBRT) in the management of non-small-cell lung cancer: Clinical impact and patient perspectives , 2018, Lung Cancer.
[15] C. Kelsey,et al. Surgery versus stereotactic body radiation therapy for stage I non–small cell lung cancer: A comprehensive review , 2018, Cancer.
[16] M. Bredel,et al. Fractionated stereotactic radiation therapy for intact brain metastases , 2017, Advances in radiation oncology.
[17] T. Zhao,et al. Effect of fractionated irradiation on the expression of multidrug resistance genes in the CNE1 human nasopharyngeal carcinoma cell line. , 2013, Molecular medicine reports.
[18] T. Murakami,et al. Involvement of Multiple Transporters-mediated Transports in Mizoribine and Methotrexate Pharmacokinetics , 2012, Pharmaceuticals.
[19] I. Goldman,et al. The antifolates. , 2012, Hematology/oncology clinics of North America.
[20] T. Wiegel,et al. Radiation- and Chemoinduced Multidrug Resistance in Colon Carcinoma Cells , 2009, Strahlentherapie und Onkologie.
[21] T. Nakanishi. Drug transporters as targets for cancer chemotherapy. , 2007, Cancer genomics & proteomics.
[22] Robert D Timmerman,et al. Stereotactic body radiation therapy. , 2004, Current problems in cancer.
[23] D. Song,et al. Stereotactic body radiation therapy. Rationale, techniques, applications, and optimization. , 2004, Oncology.
[24] Peter J. Meier,et al. Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties , 2004, Pflügers Archiv.
[25] M. Davey,et al. Fractionated irradiation of H69 small-cell lung cancer cells causes stable radiation and drug resistance with increased MRP1, MRP2, and topoisomerase IIalpha expression. , 2002, International journal of radiation oncology, biology, physics.
[26] J. Smyth,et al. Methotrexate in the chemotherapy of lung cancer. , 1981, Cancer treatment reports.
[27] D. Ross,et al. Low dose bleomycin and methotrexate in cervical cancer , 1976, Cancer.